Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05952557
Other study ID # D8535C00001
Secondary ID 2023-504031-41-0
Status Recruiting
Phase Phase 3
First received
Last updated
Start date October 5, 2023
Est. completion date May 6, 2037

Study information

Verified date June 2024
Source AstraZeneca
Contact AstraZeneca Clinical Study Information Center
Phone 1-877-240-9479
Email information.center@astrazeneca.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy). The planned duration of treatment in either arm within the study will be 7 years.


Description:

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy). The planned duration of treatment in either arm of the study is 7 years. Eligible patients must have intermediate-high or high risk of recurrence as defined by specified clinical and biologic criteria. Concurrent use of abemaciclib is permitted in both arms. The primary endpoint of the study is Invasive breast cancer-free survival (IBCFS) and main secondary endpoints include Invasive disease-free survival (IDFS), Distant relapse-free survival (DRFS), Overall survival (OS), Safety and Clinical Outcome Assessments (COAs). Patients will be followed for 10 years from randomization of the last patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 5500
Est. completion date May 6, 2037
Est. primary completion date March 4, 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years to 130 Years
Eligibility Inclusion Criteria: - Women and Men; =18 years at the time of screening (or per national guidelines) - Histologically confirmed ER+/HER2- early-stage resected invasive breast cancer with absence of any evidence of metastatic disease as defined in the protocol. - Completed adequate (definitive) locoregional therapy (surgery with or without radiotherapy) for the primary breast tumour(s), with or without (neo)adjuvant chemotherapy. - Patients must be randomised within 12 months of definitive breast surgery. - Patients may have received up to 12 weeks of endocrine therapy prior to randomisation. - Eastern Cooperative Oncology Group (ECOG) performance status of = 1 - Adequate organ and bone marrow function Exclusion Criteria: - Inoperable locally advanced or metastatic breast cancer - Pathological complete response following treatment with neoadjuvant therapy - History of any other cancer (except non-melanoma skin cancer or carcinoma in situ of the cervix or considered a very low risk of recurrence per investigator judgement) unless in complete remission with no therapy for a minimum of 5 years from the date of randomisation - Any evidence of severe or uncontrolled systemic diseases which, in the investigator's opinion precludes participation in the study or compliance " - Known LVEF <50% with heart failure NYHA Grade =2. - Mean resting QTcF interval > 480 ms at screening - Concurrent exogenous reproductive hormone therapy or non topical hormonal therapy for non-cancer-related conditions - Any concurrent anti-cancer treatment not specified in the protocol with the exception of bisphosphonates (e.g. zoledronic acid) or RANKL inhibitors ( eg, denosumab) - Previous treatment with camizestrant, investigational SERDs/investigational ER targeting agents, or fulvestrant - Currently pregnant (confirmed with positive serum pregnancy test) or breastfeeding. - Patients with known hypersensitivity to active or inactive excipients of camizestrant or drugs with a similar chemical structure or class to camizestrant. In pre-/peri-menopausal female and male patients, known hypersensitivity or intolerance to LHRH agonists that would preclude the patient from receiving any LHRH agonist.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Camizestrant
Camizestrant. Experimental. Administered orally
Tamoxifen
Tamoxifen. Comparator. Administered orally
Anastrozole
Anastrozole. Comparator. Administered orally
Letrozole
Letrozole. Comparator. Administered orally
Exemestane
Exemestane. Comparator. Administered orally
Abemaciclib
Abemaciclib adjuvant treatment Administered orally

Locations

Country Name City State
Argentina Research Site Caba
Argentina Research Site Capital Federal
Argentina Research Site Ciudad Autonoma de Buenos Aires
Argentina Research Site San Juan
Australia Research Site Bankstown
Australia Research Site Bowral
Australia Research Site Brighton
Australia Research Site Clayton
Australia Research Site Fitzroy
Australia Research Site Murdoch
Australia Research Site Richmond
Australia Research Site South Brisbane
Australia Research Site St Leonards
Australia Research Site Subiaco
Austria Research Site Graz
Austria Research Site Innsbruck
Austria Research Site Klagenfurt
Austria Research Site Linz
Austria Research Site Salzburg
Austria Research Site St. Veit an der Glan
Austria Research Site Steyr
Austria Research Site Wels
Austria Research Site Wien
Austria Research Site Wien
Austria Research Site Wien
Austria Research Site Wien
Belgium Research Site Anderlecht
Belgium Research Site Brasschaat
Belgium Research Site Bruxelles
Belgium Research Site Charleroi
Belgium Research Site Edegem
Belgium Research Site Leuven
Belgium Research Site Namur
Belgium Research Site Wilrijk
Brazil Research Site Alfenas
Brazil Research Site Belo Horizonte
Brazil Research Site Blumenau
Brazil Research Site Curitiba
Brazil Research Site Fortaleza
Brazil Research Site Goiânia
Brazil Research Site Porto Alegre
Brazil Research Site Porto Alegre
Brazil Research Site Porto Velho
Brazil Research Site Pouso Alegre
Brazil Research Site Ribeirão Preto
Brazil Research Site Rio De Janeiro
Brazil Research Site Salvador
Brazil Research Site Santo André
Brazil Research Site São Paulo
Brazil Research Site Tres Lagoas
Brazil Research Site Vitória
Bulgaria Research Site Dobrich
Bulgaria Research Site Haskovo
Bulgaria Research Site Plovdiv
Bulgaria Research Site Plovdiv
Bulgaria Research Site Sofia
Bulgaria Research Site Sofia
Bulgaria Research Site Varna
Bulgaria Research Site Vratsa
Canada Research Site Barrie Ontario
Canada Research Site Calgary Alberta
Canada Research Site Chicoutimi Quebec
Canada Research Site Edmonton Alberta
Canada Research Site Halifax Nova Scotia
Canada Research Site Kelowna British Columbia
Canada Research Site Kingston Ontario
Canada Research Site Levis Quebec
Canada Research Site Montreal Quebec
Canada Research Site Montreal Quebec
Canada Research Site North Vancouver British Columbia
Canada Research Site Quebec
Canada Research Site Saskatoon Saskatchewan
Canada Research Site Sault Ste. Marie Ontario
Canada Research Site Sudbury Ontario
Canada Research Site Thunder Bay Ontario
Canada Research Site Windsor Ontario
Chile Research Site Providencia
Chile Research Site Santiago
Chile Research Site Santiago
Chile Research Site Temuco
China Research Site Baoding
China Research Site Beijing
China Research Site Beijing
China Research Site Beijing
China Research Site Bengbu
China Research Site Binzhou
China Research Site Cangzhou
China Research Site Changchun
China Research Site Changsha
China Research Site Chengdu
China Research Site Chengdu
China Research Site Chifeng
China Research Site Dalian
China Research Site Foshan
China Research Site Fuzhou
China Research Site Guangzhou
China Research Site Guangzhou
China Research Site Haikou
China Research Site Hangzhou
China Research Site Hangzhou
China Research Site Hangzhou
China Research Site Hangzhou
China Research Site Hefei
China Research Site Hefei
China Research Site Hefei
China Research Site Hohhot
China Research Site Huizhou
China Research Site Jinzhou
China Research Site Liuzhou
China Research Site Nanchang
China Research Site Nanjing
China Research Site Nanning
China Research Site Neijiang
China Research Site Shantou
China Research Site Shaoguan Shi
China Research Site Shenyang
China Research Site Shijiahzhuang
China Research Site Suining Shi
China Research Site Suzhou
China Research Site Suzhou
China Research Site Taizhou
China Research Site WeiFang
China Research Site Wuhan
China Research Site Wuhan
China Research Site Wuhan
China Research Site Xian
China Research Site Xiangfan
China Research Site Xinxiang
China Research Site Xuzhou
Colombia Research Site Cali
Colombia Research Site Medellin
Colombia Research Site Valledupar
Croatia Research Site Rijeka
Croatia Research Site Zadar
Croatia Research Site Zagreb
Czechia Research Site Pardubice
Estonia Research Site Tallin
Estonia Research Site Tallinn
France Research Site Bordeaux
France Research Site Caen cedex 05
France Research Site Clermont-Ferrand
France Research Site Dijon
France Research Site Epagny Metz-Tessy
France Research Site Lille
France Research Site Montpellier
France Research Site Nimes
France Research Site Plerin SUR MER
France Research Site Rennes
France Research Site Rouen
France Research Site Saint Herblain
France Research Site Saint-Priest-En-Jarez
France Research Site Strasbourg
France Research Site Toulouse Cedex 09
France Research Site Vandoeuvre les Nancy
Georgia Research Site Batumi
Georgia Research Site Tbilisi
Georgia Research Site Tbilisi
Georgia Research Site Tbilisi
Georgia Research Site Tbilisi
Germany Research Site Aachen
Germany Research Site Deggendorf
Germany Research Site Düsseldorf
Germany Research Site Essen
Germany Research Site Freudenstadt
Germany Research Site Hamburg
Germany Research Site Hanau
Germany Research Site Hannover
Germany Research Site Hannover
Germany Research Site Heidelberg
Germany Research Site Karlsruhe
Germany Research Site Koblenz
Germany Research Site Köln
Germany Research Site Mainz
Germany Research Site Nurtingen
Germany Research Site Offenburg
Germany Research Site Rostock
Germany Research Site Saarbrücken
Germany Research Site Schweinfurt
Germany Research Site Wiesbaden
Germany Research Site Wiesbaden
Germany Research Site Witten
Germany Research Site Worms
Germany Research Site Wuppertal
Greece Research Site Athens
Greece Research Site Athens
Greece Research Site Athens
Greece Research Site Heraklion
Greece Research Site Ioannina
Greece Research Site Larissa
Greece Research Site Thessaloniki
Greece Research Site Thessaloniki
Hungary Research Site Budapest
Hungary Research Site Budapest
Hungary Research Site Gyor
Hungary Research Site Gyula
Hungary Research Site Kaposvár
Hungary Research Site Kecskemét
Hungary Research Site Miskolc
Hungary Research Site Nyíregyháza
Hungary Research Site Salgotarjan
Hungary Research Site Szekszárd
Hungary Research Site Zalaegerszeg
India Research Site Ansari Nagar
India Research Site Bangalore
India Research Site Belgavi
India Research Site Delhi
India Research Site Dhanvantari Nagar
India Research Site Gurgaon
India Research Site Kanpur
India Research Site Kolkata
India Research Site Mysuru
India Research Site Nagpur
India Research Site Nashik
India Research Site Nashik
India Research Site New Delhi
India Research Site New Delhi
Ireland Research Site Dublin
Ireland Research Site Dublin
Israel Research Site Beer Sheva
Israel Research Site Haifa
Israel Research Site Jerusalem
Israel Research Site Kfar Saba
Israel Research Site Nahariya
Israel Research Site Ramat Gan
Italy Research Site Bologna
Italy Research Site Brindisi
Italy Research Site Firenze
Italy Research Site Genoa
Italy Research Site Milan
Italy Research Site Milano
Italy Research Site Misterbianco
Italy Research Site Modena
Italy Research Site Monza
Italy Research Site Napoli
Italy Research Site Novara
Italy Research Site Padova
Italy Research Site Roma
Italy Research Site Roma
Italy Research Site Rozzano
Italy Research Site Torino
Italy Research Site Trento
Japan Research Site Chiba-shi
Japan Research Site Fukuoka-shi
Japan Research Site Fukushima-shi
Japan Research Site Hirakata-shi
Japan Research Site Hiroshima-shi
Japan Research Site Iruma-Gun
Japan Research Site Isehara-shi
Japan Research Site Kagoshima-shi
Japan Research Site Kashiwa
Japan Research Site Koto-ku
Japan Research Site Kumamoto-shi
Japan Research Site Kurume-shi
Japan Research Site Kyoto-shi
Japan Research Site Matsuyama-shi
Japan Research Site Nagoya-shi
Japan Research Site Nagoya-shi
Japan Research Site Nagoya-shi
Japan Research Site Niigata-shi
Japan Research Site Osaka-shi
Japan Research Site Ota-shi
Japan Research Site Sapporo-shi
Japan Research Site Sapporo-shi
Japan Research Site Sendai-shi
Japan Research Site Shinagawa-ku
Japan Research Site Suita-shi
Japan Research Site Sunto-gun
Japan Research Site Takasaki-shi
Japan Research Site Tsu-shi
Japan Research Site Yokohama-shi
Korea, Republic of Research Site Cheonan-si
Korea, Republic of Research Site Daegu
Korea, Republic of Research Site Goyang-si
Korea, Republic of Research Site Seongnam-si
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Korea, Republic of Research Site Seoul
Malaysia Research Site Johor Bahru
Malaysia Research Site Kota Bharu
Malaysia Research Site Kuala Lumpur
Malaysia Research Site Kuala Lumpur
Malaysia Research Site Kuching
Malaysia Research Site Melaka
Malaysia Research Site Pulau Pinang
Mexico Research Site Alc. Cuauhtémoc
Mexico Research Site Cancún
Mexico Research Site Colonia Lindavista
Mexico Research Site Monterrey
Mexico Research Site San Luis Potosí
Mexico Research Site Tuxtla Gutiérrez
Mexico Research Site Veracruz
New Zealand Research Site Palmerston North
Peru Research Site Arequipa
Peru Research Site Lima
Peru Research Site Lima
Philippines Research Site Bacolod
Philippines Research Site Iloilo City
Philippines Research Site Quezon
Poland Research Site Biala Podlaska
Poland Research Site Bialystok
Poland Research Site Bydgoszcz
Poland Research Site Gdansk
Poland Research Site Gdynia
Poland Research Site Grudziadz
Poland Research Site Koszalin
Poland Research Site Kraków
Poland Research Site Lódz
Poland Research Site Lublin
Poland Research Site Lublin
Poland Research Site Opole
Poland Research Site Poznan
Poland Research Site Racibórz
Poland Research Site Rzeszow
Poland Research Site Rzeszów
Poland Research Site Szczecin
Poland Research Site Tomaszów Mazowiecki
Poland Research Site Warszawa
Poland Research Site Wroclaw
Portugal Research Site Amadora
Portugal Research Site Lisboa
Portugal Research Site Porto
Portugal Research Site Viana do Castelo
Portugal Research Site Vila Nova de Gaia
Romania Research Site Bucuresti
Romania Research Site Cluj-Napoca
Romania Research Site Craiova
Romania Research Site Iasi
Romania Research Site Oradea
Romania Research Site Ovidiu
Romania Research Site Pitesti
Romania Research Site Sibiu
Romania Research Site Timisoara
Saudi Arabia Research Site Riyadh/MENA
Serbia Research Site Belgrade
Serbia Research Site Beograd
Serbia Research Site Nis
Serbia Research Site Novi Sad
Serbia Research Site Valjevo
Serbia Research Site Zrenjanin
South Africa Research Site Johannesburg
Spain Research Site A Coruña
Spain Research Site Albacete
Spain Research Site Barakaldo
Spain Research Site Barcelona
Spain Research Site Barcelona
Spain Research Site Burgos
Spain Research Site Cordoba
Spain Research Site El Palmar
Spain Research Site Elche(Alicante)
Spain Research Site Fuenlabrada
Spain Research Site Granada
Spain Research Site La Coruña
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Madrid
Spain Research Site Malaga
Spain Research Site Manresa
Spain Research Site Murcia
Spain Research Site Palma de Mallorca
Spain Research Site San Sebastian
Spain Research Site Sevilla
Spain Research Site Valencia
Spain Research Site Zaragoza
Switzerland Research Site Basel
Switzerland Research Site Bellinzona
Switzerland Research Site Chur
Switzerland Research Site Luzern
Switzerland Research Site Zürich
Taiwan Research Site Hsinchu
Taiwan Research Site Kaohsiung
Taiwan Research Site Taichung
Taiwan Research Site Taichung
Taiwan Research Site Tainan
Taiwan Research Site Taipei
Taiwan Research Site Taipei
Taiwan Research Site Taipei
Taiwan Research Site Yong Kang City
Thailand Research Site Bangkok
Thailand Research Site Bangkok
Thailand Research Site Bangkok
Thailand Research Site Bangkok
Thailand Research Site Hat Yai
Thailand Research Site Khon Kaen
Turkey Research Site Ankara
Turkey Research Site Ankara
Turkey Research Site Cigli
Turkey Research Site Edirne
Turkey Research Site Istanbul
Turkey Research Site Istanbul
Turkey Research Site Istanbul
Turkey Research Site Istanbul
Turkey Research Site Istanbul
United Arab Emirates Research Site Abu Dhabi
United Arab Emirates Research Site Al Ain
United Arab Emirates Research Site Dubai
United Arab Emirates Research Site Dubai
United Kingdom Research Site Aberdeen
United Kingdom Research Site Bath
United Kingdom Research Site Brighton
United Kingdom Research Site Cambridge
United Kingdom Research Site Guilford
United Kingdom Research Site Lancaster
United Kingdom Research Site Leeds
United Kingdom Research Site Leicester
United Kingdom Research Site London
United Kingdom Research Site London
United Kingdom Research Site London
United Kingdom Research Site Manchester
United Kingdom Research Site Northampton
United Kingdom Research Site Oxford
United Kingdom Research Site Stockton
United Kingdom Research Site Sutton
United Kingdom Research Site Sutton In Ashfield
United Kingdom Research Site Taunton
United Kingdom Research Site Warwick
United Kingdom Research Site Whitchurch
United States Research Site Annapolis Maryland
United States Research Site Appleton Wisconsin
United States Research Site Atlanta Georgia
United States Research Site Atlanta Georgia
United States Research Site Aurora Colorado
United States Research Site Austin Texas
United States Research Site Baltimore Maryland
United States Research Site Bedford Texas
United States Research Site Bethesda Maryland
United States Research Site Blue Ash Ohio
United States Research Site Boston Massachusetts
United States Research Site Boston Massachusetts
United States Research Site Charleston West Virginia
United States Research Site Charlotte North Carolina
United States Research Site Chattanooga Tennessee
United States Research Site Cincinnati Ohio
United States Research Site Cleveland Ohio
United States Research Site Columbus Ohio
United States Research Site Columbus Georgia
United States Research Site Dallas Texas
United States Research Site Dallas Texas
United States Research Site Dallas Texas
United States Research Site Des Moines Iowa
United States Research Site Duarte California
United States Research Site Durham North Carolina
United States Research Site East Syracuse New York
United States Research Site El Paso Texas
United States Research Site Elmhurst Illinois
United States Research Site Fairfax Virginia
United States Research Site Fairway Kansas
United States Research Site Farmington New Mexico
United States Research Site Fayetteville Arkansas
United States Research Site Flower Mound Texas
United States Research Site Fort Myers Florida
United States Research Site Fort Wayne Indiana
United States Research Site Fountain Valley California
United States Research Site Gainesville Florida
United States Research Site Greenbrae California
United States Research Site Greensboro North Carolina
United States Research Site Greenville South Carolina
United States Research Site Hershey Pennsylvania
United States Research Site Hooksett New Hampshire
United States Research Site Houston Texas
United States Research Site Houston Texas
United States Research Site Hyannis Massachusetts
United States Research Site Irvine California
United States Research Site Jacksonville Florida
United States Research Site Kansas City Missouri
United States Research Site Knoxville Tennessee
United States Research Site Knoxville Tennessee
United States Research Site La Jolla California
United States Research Site Lebanon New Hampshire
United States Research Site Lincoln Nebraska
United States Research Site Littleton Colorado
United States Research Site Los Angeles California
United States Research Site Louisville Kentucky
United States Research Site Marietta Georgia
United States Research Site Memphis Tennessee
United States Research Site Midlothian Virginia
United States Research Site Milwaukee Wisconsin
United States Research Site Minneapolis Minnesota
United States Research Site Monterey California
United States Research Site Morgantown West Virginia
United States Research Site Naperville Illinois
United States Research Site Nashville Tennessee
United States Research Site Nashville Tennessee
United States Research Site New Brunswick New Jersey
United States Research Site New Hyde Park New York
United States Research Site New Orleans Louisiana
United States Research Site New York New York
United States Research Site New York New York
United States Research Site Newark Delaware
United States Research Site Norfolk Virginia
United States Research Site Omaha Nebraska
United States Research Site Orlando Florida
United States Research Site Park Ridge Illinois
United States Research Site Pembroke Pines Florida
United States Research Site Philadelphia Pennsylvania
United States Research Site Pinehurst North Carolina
United States Research Site Pittsburgh Pennsylvania
United States Research Site Plainfield Illinois
United States Research Site Plano Texas
United States Research Site Plantation Florida
United States Research Site Plantation Florida
United States Research Site Puyallup Washington
United States Research Site Raleigh North Carolina
United States Research Site Richmond Virginia
United States Research Site Roanoke Virginia
United States Research Site Rock Hill South Carolina
United States Research Site Saint Louis Missouri
United States Research Site Saint Louis Missouri
United States Research Site Saint Petersburg Florida
United States Research Site Saint Petersburg Florida
United States Research Site Salt Lake City Utah
United States Research Site San Antonio Texas
United States Research Site Savannah Georgia
United States Research Site Sayre Pennsylvania
United States Research Site Scarborough Maine
United States Research Site Sioux Falls South Dakota
United States Research Site Spartanburg South Carolina
United States Research Site Spokane Washington
United States Research Site Tallahassee Florida
United States Research Site Thomasville Georgia
United States Research Site Toledo Ohio
United States Research Site Towson Maryland
United States Research Site Tyler Texas
United States Research Site Urbana Illinois
United States Research Site Vancouver Washington
United States Research Site Walnut Creek California
United States Research Site West Hollywood California
United States Research Site West Palm Beach Florida
United States Research Site White Plains New York
United States Research Site Winchester Virginia
United States Research Site Worcester Massachusetts
United States Research Site York Pennsylvania
United States Research Site Youngstown Ohio
United States Research Site Ypsilanti Michigan

Sponsors (2)

Lead Sponsor Collaborator
AstraZeneca Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Bulgaria,  Canada,  Chile,  China,  Colombia,  Croatia,  Czechia,  Estonia,  France,  Georgia,  Germany,  Greece,  Hungary,  India,  Ireland,  Israel,  Italy,  Japan,  Korea, Republic of,  Malaysia,  Mexico,  New Zealand,  Peru,  Philippines,  Poland,  Portugal,  Romania,  Saudi Arabia,  Serbia,  South Africa,  Spain,  Switzerland,  Taiwan,  Thailand,  Turkey,  United Arab Emirates,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Invasive breast cancer-free survival (IBCFS) IBCFS is defined as time from randomisation until date of first occurrence of:
Invasive ipsilateral breast tumour recurrence
Locoregional invasive breast cancer recurrence
Distant recurrence
Contralateral invasive breast cancer
Death attributable to any cause.
Up to 14 years
Secondary Invasive disease-free survival (IDFS) IDFS is defined as time from randomisation until date of first occurrence of one of the following events:
Invasive ipsilateral breast tumor recurrence
Locoregional invasive breast cancer recurrence
Distant recurrence
Contralateral invasive breast cancer
Second primary non-breast invasive cancer
Death attributable to any cause.
Up to 14 years
Secondary Distant relapse-free survival (DRFS) DRFS is defined as time from randomisation until date of first distant recurrence or death from any cause, whichever occurs first. Up to 14 years
Secondary Overall survival (OS) OS is defined as time from randomisation until death from any cause. Up to 14 years
Secondary Incidence and Severity of Adverse Events, with Severity Determined According to National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0 (NCI-CTCAE v5.0) Until 28 days after the final dose of study treatment (up to 7 years)
Secondary Proportion of time on study treatment with high side-effect burden as measured by the PGI-TT. Until 28 days after the final dose of study treatment (up to 7 years)
Secondary Change from baseline and time to deterioration of health-related quality of life as measured by the 2 global QoL items from the EORTC IL-311 Until 28 days after the final dose of study treatment (up to 7 years)
Secondary Pharmacokinetics (PK) Plasma concentrations of camizestrant pre-dose (trough concentration) Until 6 months from treatment start
See also
  Status Clinical Trial Phase
Recruiting NCT05774951 - A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy Phase 3
Completed NCT02443467 - A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer N/A